Plasma lipoprotein responses to enzyme-replacement in Gaucher's disease

Lancet

Volumn 353, Issue 9153, 1999, Pages 642-643

  Cenarro, Ana ^a   Pocovi, Miguel ^b   Giraldo, Pilar ^c   Garciaotin, Angel L ^a,b   Ordovas, Jose M ^b  

^a TUFTS UNIVERSITY   (United States)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^c UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; ENZYME REPLACEMENT; FEMALE; GAUCHER DISEASE; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; PRIORITY JOURNAL;

EID: 0033024391     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)00188-9     Document Type: Article

References (5)

1. Beutler E, Grabowski GA. Gaucher disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular basis of inherited disease, 7th edn. New York: McGraw-Hill, 1995: 2641-70.
2. Pocovi M, Cenarro A, Civeira F, et al. Beta-glucocerebroside gene locus as a link for Gaucher's disease and familial hypo-alpha-lipoproteinemia. Lancet 1998; 351: 1919-23.
3. Mahley RW. Apolipoprotein E. A cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622-30.
4. Grabowski GA, Leslie N, Wenstrup R. Enzyme therapy for Gaucher disease: the first five years. Blood Rev 1998; 12: 115-33.
5. Zhang WY, Gaynor PM, Kruth HS. Apolipoprotein E produced by human monocyte-derived macrophages mediates cholesterol efflux that occurs in the absence of added cholesterol acceptors. J Biol Chem 1996; 271:28641-46.